Premium
Viatris Inc (VTRS)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
We are Viatris. A new kind of global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines advance sustainable operations develop innovative solutions and leverage our collective expertise to connect more people to more products and s... We are Viatris. A new kind of global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines advance sustainable operations develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway. Formed in November 2020 we bring together scientific manufacturing and distribution expertise with proven regulatory medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. At Viatris our portfolio comprises more than 1400 approved molecules across a wide range of therapeutic areas spanning both non-communicable and infectious diseases including globally recognized brands complex generic and branded medicines and a growing portfolio of biosimilars. Show more
Viatris to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 PR Newswire PITTSBURGH, Feb. 3, 2025 PITTSBURGH, Feb. 3, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ:...
Viatris to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire PITTSBURGH, Jan. 7, 2025 PITTSBURGH, Jan. 7, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global...
Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology PR Newswire PITTSBURGH, Dec. 18, 2024 Biomarker data from CARE study characterizing cenerimod's...
Viatris Reports Third Quarter Financial Results for 2024 PR Newswire PITTSBURGH, Nov. 7, 2024 PITTSBURGH, Nov. 7, 2024 /PRNewswire/ -- Total Revenues of $3.8 Billion and Operational...
Viatris Announces Third Quarter 2024 Dividend PR Newswire PITTSBURGH, Nov. 5, 2024 PITTSBURGH, Nov. 5, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on November 4, 2024...
Viatris Named to Forbes' World's Top Companies for Women 2024 List PR Newswire PITTSBURGH, Oct. 29, 2024 PITTSBURGH, Oct. 29, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare...
Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference PR Newswire PITTSBURGH, Oct. 29, 2024 PITTSBURGH, Oct. 29, 2024 /PRNewswire/ -- Viatris...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.615 | -5.3711790393 | 11.45 | 11.51 | 10.73 | 11814655 | 11.16048033 | CS |
| 4 | -0.995 | -8.41081994928 | 11.83 | 12.02 | 10.73 | 10472586 | 11.32126914 | CS |
| 12 | -2.2 | -16.8776371308 | 13.035 | 13.55 | 10.73 | 9185696 | 12.18185909 | CS |
| 26 | -0.635 | -5.53618134263 | 11.47 | 13.55 | 10.73 | 8404651 | 11.94437612 | CS |
| 52 | -0.835 | -7.15509854327 | 11.67 | 13.6175 | 9.925 | 8583077 | 11.74164555 | CS |
| 156 | -4.421 | -28.9787624541 | 15.256 | 15.6 | 8.42 | 9696038 | 10.84797371 | CS |
| 260 | -5.625 | -34.1737545565 | 16.46 | 18.86 | 8.42 | 9737919 | 12.08030978 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
